Correlation Between Transcode Therapeutics and Bolt Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Bolt Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Bolt Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Transcode Therapeutics and Bolt Biotherapeutics, you can compare the effects of market volatilities on Transcode Therapeutics and Bolt Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Bolt Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Bolt Biotherapeutics.

Diversification Opportunities for Transcode Therapeutics and Bolt Biotherapeutics

0.69

Correlation Coefficient

Transcode Therapeutics  Bolt Biotherapeutics

Poor diversification

The 3 months correlation between Transcode and Bolt is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Bolt Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bolt Biotherapeutics and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Bolt Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bolt Biotherapeutics has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Bolt Biotherapeutics go up and down completely randomly.

Pair Corralation between Transcode Therapeutics and Bolt Biotherapeutics

Given the investment horizon of 90 days Transcode Therapeutics is expected to generate 1.11 times more return on investment than Bolt Biotherapeutics. However, Transcode Therapeutics is 1.11 times more volatile than Bolt Biotherapeutics. It trades about 0.18 of its potential returns per unit of risk. Bolt Biotherapeutics is currently generating about 0.17 per unit of risk. If you would invest  1,065  in Transcode Therapeutics on July 30, 2025 and sell it today you would earn a total of  249.00  from holding Transcode Therapeutics or generate 23.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Transcode Therapeutics  vs.  Bolt Biotherapeutics

Transcode Therapeutics

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Transcode Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Transcode Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Bolt Biotherapeutics

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Bolt Biotherapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Bolt Biotherapeutics may actually be approaching a critical reversion point that can send shares even higher in November 2025.

Pair Trading with Transcode Therapeutics and Bolt Biotherapeutics

The main advantage of trading using opposite Transcode Therapeutics and Bolt Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Bolt Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will offset losses from the drop in Bolt Biotherapeutics' long position.

The idea behind Transcode Therapeutics and Bolt Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.